About the job
Zenas BioPharma is a forward-thinking clinical-stage global biopharmaceutical company dedicated to leading the development and commercialization of groundbreaking therapies for patients suffering from autoimmune diseases. Our strategy leverages the expertise of our seasoned leadership team combined with a meticulous approach to the acquisition and development of product candidates that we believe will provide significant clinical advantages for patients with autoimmune disorders. Zenas is actively progressing two late-stage potential franchise molecules: obexelimab and orelabrutinib. Obexelimab—our flagship product candidate—is a bifunctional monoclonal antibody engineered to bind to both CD19 and FcγRIIb, which are extensively expressed across B cell lineages. This innovative approach aims to inhibit the activity of cells involved in various autoimmune diseases without depleting them. We are confident that obexelimab’s unique mechanism of action and its self-administered, subcutaneous injection regimen will effectively target the harmful role of B cells in chronic autoimmune conditions. Orelabrutinib is a potentially best-in-class, highly selective oral small molecule Bruton’s Tyrosine Kinase (BTK) inhibitor, designed to address focal inflammation and disease progression in Multiple Sclerosis (MS). Our earlier-stage programs include a preclinical oral IL-17AA/AF inhibitor and a preclinical oral brain-penetrant TYK2 inhibitor.
We are in search of exceptional talent who are passionate about making a difference in patients' lives and possess a proven track record in the global acquisition, development, and commercialization of pharmaceutical products. Joining our team offers the chance to thrive in a dynamic, fast-paced environment while contributing to our mission of becoming a global leader in immunology and autoimmune disease treatment. Our core values are Transparency, Relationships, Urgency, Excellence, and true Innovation!
Position Summary:
The Senior Director of Access Strategy & Patient Services will be pivotal in strategizing and leading our patient access initiatives, ensuring smooth operations for patient services to facilitate timely and appropriate access to Zenas BioPharma therapies. Reporting directly to the Vice President of U.S. Market Access, this role will oversee the development of the patient journey strategy, the HUB services model, affordability programs, and the onboarding processes for providers to help both patients and providers navigate access to therapy effectively.
This role is crucial in establishing the patient access infrastructure ahead of significant product launches, operationalizing the patient support HUB, and designing prior authorization support systems to enhance patient access.